Fintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...

In today’s CEO Daily: Jason Del Rey talks to Chewy CEO Sumit Singh about chaos, pets, and recessions. The big story: Trump ...

The move will see 3% to 5% of the bank’s global workforce of 46,500 cut, sources familiar with the matter told The Post.

Goldman Sachs initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target Discover the Best Stocks and Maximize ...

Goldman Sachs analyst Salveen Richter initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target a Summit’s lead ...

U.S. President Donald Trump's decision to impose tariffs is part of a plan to "level the playing field" that he views as ...

Goldman Sachs has removed its 'diversity and inclusion' section from annual filings to comply with U.S. law, while affirming ...